Literature DB >> 11045704

Assessment of the presence and severity of esophagogastric varices by splenic index in patients with liver cirrhosis.

S Watanabe1, N Hosomi, Y Kitade, K Kurokohchi, K Arima, H Kawabata, Y Uchida, M Nishioka.   

Abstract

PURPOSE: To determine whether spleen size is related to the severity of esophageal varices or associated gastric varices and liver functions in patients with cirrhosis.
METHOD: The authors retrospectively studied spleen size on CT (splenic index [SI] = length x width x height of the spleen), liver functions, and the results of esophagogastric endoscopy in 110 patients with cirrhosis. They also analyzed SI in 112 controls.
RESULTS: In controls, body weight, height, and age affected the SI. The SI in patients with uncompensated cirrhosis was greater compared with the SI in those with well-compensated disease (p = 0.0363). The SI in patients with esophageal varices was greater than in patients without esophageal varices (p<0.0001), but patients with and without gastric varices had similar SI values. The SI in patients with the red color signs (red wale marking, cherry red spot, and hematocystic spot) on esophageal varices or with risky varices (enlarged tortuous varices with beady, nodular, or tumor shape associated with red color signs) was greater than in patients without these signs (p = 0.0029 and p = 0.0030, respectively).
CONCLUSION: The SI is a good indicator of the severity of esophageal varices and hepatic functional reserve in patients with cirrhosis.

Entities:  

Mesh:

Year:  2000        PMID: 11045704     DOI: 10.1097/00004728-200009000-00022

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Hepatic sinusoidal obstruction associated with S-1 plus cisplatin chemotherapy for highly advanced gastric cancer with paraaortic lymph node metastases: report of a case.

Authors:  Hirofumi Toi; Yosuke Miura; Susumu Shibasaki; Kenji Chisaka; Manabu Goto; Ichiro Tsuda; Takahisa Nakamura; Taiji Hase
Journal:  Clin J Gastroenterol       Date:  2012-09-18

2.  Splenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy.

Authors:  Kazuhiro Miura; Hiroshi Nakano; Joe Sakurai; Shinjiro Kobayashi; Satoshi Koizumi; Tatsuhiro Arai; Tsukasa Shimamura; Ryoji Makizumi; Kyoji Yamada; Nobuyoshi Miyajima; Takehito Otsubo; Junki Koike
Journal:  Int J Clin Oncol       Date:  2011-01-18       Impact factor: 3.402

3.  Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension.

Authors:  Tamara Alempijevic; Vladislava Bulat; Srdjan Djuranovic; Nada Kovacevic; Rada Jesic; Dragan Tomic; Slobodan Krstic; Miodrag Krstic
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

4.  Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance.

Authors:  Enrico Maria Zardi; Valentina Uwechie; Domenico Caccavo; Nelly Maria Pellegrino; Fabio Cacciapaglia; Francesco Di Matteo; Aldo Dobrina; Vittorio Laghi; Antonella Afeltra
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

5.  Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices.

Authors:  Jiuquan Zhang; Ran Tao; Zhonglan You; Yongming Dai; Yi Fan; Jinguo Cui; Qing Mao; Jian Wang
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

6.  Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.

Authors:  Sehhoon Park; Hwi Young Kim; Haeryoung Kim; Jin Hyun Park; Jung Ho Kim; Ki Hwan Kim; Won Kim; In Sil Choi; Yong Jin Jung; Jin-Soo Kim
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.